Extended Data Fig. 4: Biomarker analyses by Trop2 expression levels. | Nature Medicine

Extended Data Fig. 4: Biomarker analyses by Trop2 expression levels.

From: Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials

Extended Data Fig. 4

Objective response rate (ORR, left) and progression-free survival (PFS, right) by Trop2 expression levels in patients from two studies (A, n = 92), from KL264-01 cohort 3A (B, n = 34); fromSKB264-II-08 cohort 1 and cohort 2 (C, N = 58). The bar indicates point estimate of ORR; error bar indicates 95% confidence interval (CI). PFS is displayed as median and 95%CI.

Back to article page